Structure Therapeutics, Inc. Sponsored ADR Cash Flow
GPCR's free cash flow for Q3 2024 was $-20.38M. For the 2024 fiscal year, GPCR's free cash flow was decreased by $-35.38M and operating cash flow was $-19.70M. See a summary of the company’s cash flow.
Cash Flow
Dec 23
Dec 22
Dec 21
Dec 20
Operating Cash Flow
$ -79.49M
$ -46.12M
$ -32.16K
$ -14.28K
Investing Cash Flow
$ -268.34M
$ -62.11M
$ 17.86K
$ -21.15K
Financing Cash Flow
$ 451.53M
$ 29.01M
$ 103.25K
$ 25.84K
End Cash Position
$ 129.79M
$ 26.09M
$ 105.31K
$ 16.35K
Free Cash Flow
$ -81.66M
$ -46.27M
$ -33.37K
$ -14.30K
Currency in USD
Structure Therapeutics, Inc. Sponsored ADR Cash Flow